Medium materiality6/10
Fate Therapeutics price target raised to $3.50 from $2.50 at Wells Fargo
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises Fate Therapeutics target to $3.50; current price $2.52; price up ~1.98% since signal.
- Target: $3.50
- Posted price: $2.52
- Analyst firm: Wells Fargo
Key facts
- 01
Target: $3.5
- 02
Posted price: $2.52
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.